PHASE-I TOLERABILITY - PHARMACOLOGICAL STUDY OF CGP48664, A NOVEL POLYAMINE BIOSYNTHESIS INHIBITOR, GIVEN IV ONCE WEEKLY X 4 (Q 6 WKS) TO PATIENTS WITH SOLID TUMORS

Authors
GREIM G ESKENS F HOPPENER F BARBET NC CHOI L HANAUSKE AR VERWEIJ J BRUNTSCH U
Citation
G. Greim et al., PHASE-I TOLERABILITY - PHARMACOLOGICAL STUDY OF CGP48664, A NOVEL POLYAMINE BIOSYNTHESIS INHIBITOR, GIVEN IV ONCE WEEKLY X 4 (Q 6 WKS) TO PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 443-443
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
443 - 443
Database
ISI
SICI code
0923-7534(1998)9:<443:PT-PSO>2.0.ZU;2-0